Cumberland Seeks To Block Perrigo's Generic Acetadote

Law360, New York (August 10, 2012, 3:10 PM EDT) -- Cumberland Pharmaceuticals Inc. on Thursday continued its campaign to protect its acetaminophen-overdose treatment Acetadote from challengers, accusing generics maker Perrigo Co. of patent infringement in Illinois federal court.

Cumberland alleges that Perrigo is seeking to undermine Cumberland's business by looking for regulatory approval to market an Acetadote copy prior to the expiration of the original drug's underlying patent issued in April of this year, U.S. Patent Number 8,148,356, titled, "Acetylcysteine composition and uses therefore."

"Perrigo has knowledge of the '356 patent, and Perrigo's actions constitute knowing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.